UAE Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2028

UAE Pharmaceuticals Market is stood at USD 4009.31 million in 2022 and is expected to grow at steady rate of 7.96% during the forecast period, on the account of rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, respiratory problems, renal disorders, and others in the country requiring effective treatment is expected to drive the growth of UAE pharmaceutical market during the forecast period. For instance, according to the global cancer observatory, in 2020, about 4807 number of new cases in UAE were of cancer. Out of which, 1030 were of breast cancer, 510 were of colorectum, 405 were of thyroid, 272 were of leukemia, 270 were of prostate, and 2380 were of other kinds of cancers. Furthermore, the increasing disease burden has led to surge in the demand of pharmaceuticals products, which is expected to bolster the growth of the market. These factors are actively driving the growth of the UAE Pharmaceuticals Market in the upcoming five years, 2024-2028.

One of the key drivers of growth in the UAE pharmaceutical market is an aging population. As people get older, they are more likely to require medication to treat chronic conditions such as diabetes, heart disease, and arthritis. This has led to an increase in demand for medications and has created a large and growing market for pharmaceutical companies. Another factor driving growth in the UAE pharmaceutical market is increasing healthcare spending. The government has made healthcare a priority and has allocated significant resources to improve healthcare infrastructure and services. This has created a favorable environment for pharmaceutical companies, with a growing demand for drugs and therapies.

Additionally, the market growth can be attributed to the expanding healthcare infrastructure in the country and high investments by market players in developing effective drugs and medicines, infectious disorders brought by increased tourism and environmental factors is expected to drive the growth of the market.

Furthermore, the consistent research and technological advancement in the manufacturing of drugs is expected to aid the growth of the UAE Pharmaceuticals Market in the forecast period, in the forecast period of 2024-2028. Moreover, the government supports the idea by increasing investment in the pharmaceutical sector and the pharmaceutical companies are forced to manufacture pharmaceuticals products in the country.

Rise Prevalence of Diseases

The increase in number of chronic diseases, infectious diseases, and lifestyle diseases are the major factor influencing the growth of the pharmaceutical market in the country. Chronic diseases like cardiovascular diseases, cancer, neurological disorders, etc. are driving the market growth. According to the research articles, health experts say at least 50 percent of heart attack patients in the UAE are under the age of 50, as doctors warn obesity and sedentary lifestyles are creating a generation prone to cardiovascular disease.

Government Initiatives

United Arab Emirates' government is actively focused on developing the technology and the advancement in the pharmaceutical industry. Several initiatives were taken within the country like Dubai Industrial Strategy 2030 and Abu Dhabi vision 2030 is focused towards developing the pharmaceutical industry due to its future growth prospects, export potential and mid-term to long-term economic impact. In the recent years, majorly the pharmaceutical demands were fulfilled by imported drugs and products. Therefore, the market players are increasing their manufacturing of pharmaceutical products, thereby initiating to strengthen bonds with multinational market players. Government is preparing favorable schemes and plans for the distribution channels and funding strategic location and sophisticated logistics infrastructure to further strengthen the growth of the UAE pharmaceutical market in the future five years.

The UAE's government's initiatives to increase and improve healthcare access will be aided by rising support from the business sector. The National Unified Medical Record system and the Public Health Management platform, both aim to use digital health solutions to foster collaboration between the public and private sectors, while promoting and monitoring public health initiatives, and improving the overall provision of healthcare, that has been introduced by the UAE's Ministry of Health and Prevention over the course of 2021. According to the International Diabetes Federation, in 2021, out of 1000s, about 990 Emiratis were suffering from diabetes. Additionally, the growing research and development activities in the pharmaceutical industry is projected to augment the growth of the UAE pharmaceutical market in the forthcoming years.

Moreover, the pharmaceutical market in the UAE is dominated by multinational companies such as Pfizer, Novartis, Roche, and Sanofi. These companies have a strong presence in the country and invest heavily in research and development to bring new drugs and therapies to market. In addition to these major players, there are other smaller companies and startups that focus on developing drugs for niche markets.

Increase in Medical Tourism

The UAE government is rapidly expanding its medical tourism industry. Because of its position, The Emirates is a convenient destination for tourists. In the United Arab Emirates, cancer therapy is the most sought-after medical service. This attracts around 400 thousand patients worldwide. Dental surgery is gaining interest and over the next decade, it will be a booming business in the country. The facilities for other forms of treatments including surgeries and orthopedic treatments are available. 

Recent Developments

In January 2022, the UAE’s Ministry of Health and Prevention signed a memorandum of understanding with a strong market player namely Bayer Middle East to launch a new educational initiative "STEPS" (Development and Training for Excellence in Clinical Pharmacy Systems). The new initiative aims to support the local health authorities by developing the capabilities of the various components of the medical system, such as regulators, suppliers, and pharmacists, through the provision of training modules on health economics with the aim of educating the medical community on best healthcare practices. 

Additionally, in January 2022, ADQ, one of Abu Dhabi’s largest sovereign wealth funds, entered into an agreement to consolidate several companies in order to create the UAE’s largest healthcare provider. The new healthcare platform will operate through Alpha Dhabi’s unit, Pure Health Medical Supplies, a UAE-based integrated healthcare solutions provider. As part of consolidatory efforts, Pure Health, which already has a diversified service portfolio of hospital management, laboratory services, medical supplies, and healthcare informatics, will improve efficiencies and optimize healthcare expenditure across the value chain. 

In December 2021, AstraZeneca and Abu Dhabi’s G42 Healthcare announced a partnership to boost clinical research and diagnostics’ frameworks in the UAE. They also investigate real-world genomics evidence as part of the collaboration, and G42 Healthcare's Biogenix Labs use to provide full clinical diagnostic services.

Download Free Sample Report 

Market Segmentation

The UAE Pharmaceuticals Market is segmented by drug type, product type, application, distribution channel, region, and competition landscape. Based on drug type, the market is further bifurcated into generic drugs and branded drugs. Based on product type, the market is segmented into over-the-counter drugs and prescription drugs. Based on application, the market is segmented into cardiovascular, oncology, metabolic disorder, musculoskeletal, anti-infective, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy.

Market Players

Pfizer UAE, Johnson & Johnson Middle-East, GlaxoSmithKline & Neopharma, Julphar Gulf Pharmaceutical Ind, Roche Pharmaceuticals Middle East FZCO, Niner Pharmaceuticals LLC, Lifepharma FZE, Hikma Pharmaceuticals, etc. are some of the leading companies operating in the UAE Pharmaceuticals Market.

Report Scope:

In this report, UAE Pharmaceuticals Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• UAE Pharmaceuticals Market, By Drug Type:

o   Generic Drugs

o   Branded Drugs

• UAE Pharmaceuticals Market, By Product Type:
• Over-The-Counter Drugs
• Prescription Drugs
• UAE Pharmaceuticals Market, By Application:
• Cardiovascular
• Oncology
• Metabolic Disorder
• Musculoskeletal
• Anti-infective
• Others
• UAE Pharmaceuticals Market, By Distribution Channel:
• Retail Pharmacy
• Hospital Pharmacy
• E-Pharmacy
• UAE Pharmaceuticals Market, By Region:
• Abu Dhabi
• Dubai
• Sharjah
• Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE Pharmaceuticals Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information:

• Detailed analysis and profiling of additional market players (up to five).

UAE Pharmaceutical Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com